[S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators]

Urologe A. 2016 Sep;55(9):1188-91. doi: 10.1007/s00120-016-0196-0.

[Article in German]

Authors

M Retz¹, P Maisch², J E Gschwend²

Affiliations

¹ Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland. margitta.retz@tum.de.
² Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.

PMID: 27581238
DOI: 10.1007/s00120-016-0196-0

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use
Combined Modality Therapy / methods
Cystectomy / methods*
Evidence-Based Medicine
Germany
Guideline Adherence / standards
Humans
Medical Oncology / standards*
Practice Guidelines as Topic*
Quality Assurance, Health Care / standards
Quality Control
Treatment Outcome
Urinary Bladder Neoplasms / diagnosis*
Urinary Bladder Neoplasms / therapy*
Urology / standards*

Substances

Antineoplastic Agents